In last trading session, TransCode Therapeutics Inc (NASDAQ:RNAZ) saw 95599.0 shares changing hands with its beta currently measuring 0.75. Company’s recent per share price level of $3.43 trading at -$0.18 or -4.99% at ring of the bell on the day assigns it a market valuation of $2.38M. That closing price of RNAZ’s stock is at a discount of -6807.87% from its 52-week high price of $236.94 and is indicating a premium of 6.41% from its 52-week low price of $3.21. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.1 million shares which gives us an average trading volume of 57.60K if we extend that period to 3-months.
TransCode Therapeutics Inc (NASDAQ:RNAZ) trade information
Upright in the red during last session for losing -4.99%, in the last five days RNAZ remained trading in the green while hitting it’s week-highest on Tuesday, 01/07/25 when the stock touched $3.43 price level, adding 14.68% to its value on the day. TransCode Therapeutics Inc’s shares saw a change of 1.78% in year-to-date performance and have moved 1.78% in past 5-day. TransCode Therapeutics Inc (NASDAQ:RNAZ) showed a performance of -55.63% in past 30-days. Number of shares sold short was 0.74 million shares which calculate 0.5 days to cover the short interests.
TransCode Therapeutics Inc (RNAZ) estimates and forecasts
Statistics highlight that TransCode Therapeutics Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -88.45% of value to its shares in past 6 months, showing an annual growth rate of 99.86% while that of industry is 16.70. Apart from that, the company came raising its revenue forecast for fiscal year 2025.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -28.81% during past 5 years.
TransCode Therapeutics Inc (NASDAQ:RNAZ)’s Major holders
Insiders are in possession of 0.01% of company’s total shares while institution are holding 1.99 percent of that, with stock having share float percentage of 1.99%. Investors also watch the number of corporate investors in a company very closely, which is 1.99% institutions for TransCode Therapeutics Inc that are currently holding shares of the company.
